Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors

Area of Science:

• Stem Cell Biology
• Mitochondrial Genetics
• Neuroscience

Background:

• Neurodegenerative disorders are often linked to mitochondrial genome defects.
• Human neural progenitor (hNP) cells are crucial for studying neural development and disease.
• Efficient manipulation of mitochondria in hNP cells is needed for disease modeling.

Purpose of the Study:

• To develop a method for introducing pathogenic mitochondrial DNA (mtDNA) into hNP cells.
• To create a stem cell-based model for studying mitochondrial defects in neurodegenerative diseases.
• To assess the impact of mtDNA manipulation on hNP cell phenotype and differentiation.

Main Methods:

• Treatment of hNP cells with dideoxycytidine (ddC) to reduce endogenous mtDNA.
• Transfection of ddC-treated hNPs with pathogenic G11778A mtDNA complexed with recombinant human mitochondrial transcription factor A (rhTFAM).
• Confirmation of mtDNA entry, expression, and subsequent neuronal differentiation.

Main Results:

• ddC treatment effectively reduced mtDNA without compromising hNP cell markers.
• rhTFAM facilitated the entry and expression of pathogenic G11778A mtDNA into hNP cells.
• Introduced pathogenic mtDNA did not impede neuronal differentiation, confirmed by beta-tubulin expression.

Conclusions:

• Pathogenic mtDNA can be successfully introduced and expressed in hNP cells.
• This method preserves hNP cell phenotype and neuronal differentiation potential.
• Mitochondrial gene replacement technology offers a novel approach for in vitro modeling of neurodegenerative disorders.